Abstract
In this work, we portray a new controlled nitric oxide (NO) delivery platform by grafting S-nitrosothiol derived from cysteine into the polymeric backbone of poly(vinyl methyl ether-co-maleic anhydride). Nitrosothiols (RSNO’s) are linked to the polymeric backbone through solvent displacement method. By adjusting solvent polarity, materials of different shapes and sizes varying between μm and nm are prepared. More often our method of preparation resulted in hexagonally shaped polymeric materials. The structure and RSNO conjugation analysis was investigated using scanning electron microscopy (SEM), FT-IR, UV–Vis spectroscopy and thermogravimetric analysis (TGA). Bactericidal efficacy of nitric oxide releasing polymer hexagons, a novel antibacterial agent is demonstrated against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. Confocal microscopic studies revealed the enhanced bactericidal effect of polymer hexagons via membrane destruction. Results suggest that this biocompatible NO releasing RSNO conjugated polymer hexagons could be potentially useful for antimicrobial applications.
Graphical Abstract
Similar content being viewed by others
References
Ignarro LJ. Nitric oxide: biology and pathobiology. San Diego: Academic Press; 2000. p. 209–24.
Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31:577–97.
Hill BG, Dranka BP, Bailey SM, Lancaster JR, Darley-Usmar VM. What part of NO don’t you understand? Some answers to the cardinal questions in nitric oxide biology. J Biol Chem. 2010;285:19699–704.
Zhang J, Snyder SH. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol. 1995;35:213–33.
Fang FC. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol. 2004;2:820–32.
DeGroote MA, Fang FC. Antimicrobial properties of nitric oxide. In: Fang FC, editor. Nitric oxide and infection. New York: Kluwer Academic/Plenum Publishers; 1999. p. 231–61.
Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997;77:637–50.
Bad bugs, no drugs: as antibiotic discovery stagnates, a public health crisis brews. Arlington, VA: Infectious Diseases Society of America; 2004. p. 1–35.
Barrett CT, Barrett JF. Antibacterials: Are the new entries enough to deal with the emerging resistance problems? Curr Opin Biotechnol. 2003;14:621–6.
Wenzel RP, Bearman G, Edmond MB. Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents. 2007;3:210–2.
Bearman GML, Munro C, Sessler CN, Wenzel RP. Infection control and the prevention of nosocomial infections in the intensive care unit. Semin Respir Crit Care Med. 2006;27:310–24.
Chastre J. Evolving problems with resistant pathogens. CMI. 2008;14(3):3–14.
Bodmann KF. Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy. 2005;51:227–33.
Gu H, Ho PL, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 2003;3:1261–3.
Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346–53.
Sambhy V, MacBride MM, Peterson BR, Sen A. Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials. J Am Chem Soc. 2006;128:9798–808.
Panacek A, Kvitek L, Prucek R, Kolar M, Vecerova R, Pizurova N, Sharma VK, Nevecna T, Zboril R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110:16248–53.
Trewyn BG, Whitman CM, Lin VSY. Mesoporous silica nanoparticles for intracellular delivery of membrane. Nano Lett. 2004;4:2139–43.
Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99:2818–25.
Ghaffari A, Miller CC, McMullin B, Ghahary A. Potential application of gaseous nitric oxide as a topical antimicrobial agent. Nitric Oxide. 2006;14:21–9.
Wang PG, Xian M, Tang X, Wu X, Wen Z, Cai T, Janczuk AJ. Nitric oxide donors: chemical activities and biological applications. Chem Rev. 2002;102:1091–134.
Napoli C, Ignarro LJ. Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol. 2003;43:97–123.
Miller MR, Megson IL. Recent developments in nitric oxide donor drugs. Br J Pharmacol. 2008;151:305–21.
Kroncke KD, Suschek CV. Adulterated effects of nitric oxide-generating donors. J Invest Dermatol. 2008;128:258–60.
Bauer JA, Rao W, Smith DJ. Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity. Wound Repair Regen. 1998;6:569–77.
Richardson G, Benjamin N. Potential therapeutic uses for S-nitrosothiols. Clin Sci. 2002;102:99–105.
Williams DLH. The mechanism of nitric oxide formation from S-nitrosothiols. Chem Commun. 1996;10:1085–91.
Roy B, diHardemare AD, Fontecave M. New thionitrites: synthesis, stability, and nitric oxide generation. J Org Chem. 1994;59:7019–26.
Lu D, Nadas J, Zhang G, Johnson W, Zweier JL, Cardounel AJ, Villamena FA, Wang PG. 4-Aryl-1,3,2-oxathiazolylium-5-olates as pH-controlled NO-donors: the next generation of S-nitrosothiols. J Am Chem Soc. 2007;129:5503–14.
Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35:780–9.
Shin JH, Schoenfisch ME. Reducing implant-related infections: active release strategies. Analyst. 2006;131:609–15.
Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials. 2009;30:2782–9.
Deupree SM, Schoenfisch MH. Morphological analysis of the antimicrobial action of nitric oxide on gram-negative pathogens using atomic force microscopy. Acta Biomater. 2009;5:1405–15.
Carpenter AW, Slomberg DL, Rao KS, Schoenfisch MH. Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles. ACS Nano. 2011;3:426–32.
Skrzypchak AM, Lafayette NG, Bartlett RH, Zhou Z, Frost MC, Meyerhoff ME, Reynolds MM, Annich GM. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation. Perfusion. 2007;22:193–200.
Jordan SW, Chaikof EL. Novel thromboresistant materials. J Vasc Surg. 2007;45:104A.
Seabra AB, da Silva R, de Souza GFP, de Oliveira MG. Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces. ArtifiOrgans. 2008;32:262–70.
Coneski PN, Rao KS, Schoenfisch MH. Degradable nitric oxide-releasing biomaterials via post-polymerization functionalization of cross-linked polyesters. Biomacromolecule. 2010;11:3208–12.
Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med. 1994;120:227–32.
Nablo BJ, Prichard HL, Butler RD, Klitzman B, Schoenfisch MH. Inhibition of implant-associated infections via nitric oxide release. Biomaterials. 2005;26:6984–90.
Seabra AB, Pankotai E, Feher M, Somlai A, Kiss L, Biro L, Szabo C, Kollai M, De Oliveira MG, Lacza Z. S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. Br J Dermatol. 2007;156:814–8.
Majo TC, Brant DO, Reynolds MM, Bartlett RH, Meyerhoff ME, Handa H, Annich GM. The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. Biomaterials. 2010;31:2736–40.
Hetrick EM, Shin JH, Stasko NA, Johnson B, Wespe AD, Holmuhamedov E, Schoenfisch MH. Bacterial efficacy of nitric oxide releasing silica nanoparticles. ACS Nano. 2008;2:235–42.
Arbos P, Wirth M, Arangoa MA, Gabor F, Irache JM. Gatrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates. J Control Release. 2002;83:321–30.
Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery application. Chem Soc Rev. 2012;41:2545–61.
Arbos P, Arangoa MA, Campanero MA, Irache JM. Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles. Int J Pharm. 2002;242:129–36.
Hobbie JE, Daley RJ, Jasper S. Use of nuclepore filters for counting bacteria by fluorescence microscopy. Appl Environ Microbiol. 1997;33:1225–8.
Tas J, Westerneng G. Fundamental aspects of the interaction of propidium diiodide with nucleic acids studied in a model system of polyacrylamide films. J Histochem Cytochem. 1981;29:929–36.
Hetrick EM, Schoenfisch MH. Analytical chemistry of nitric oxide. Annu Rev Anal Chem. 2009;2:409–33.
Li Yan, Lee Ping I. Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Mol Pharm. 2009;7:254–66.
Basu S, Hill JD, Shields H, Huang J, Bruce King S, Kim-Shapiro DB. Hemoglobin effects in Saville assay. Nitric Oxide. 2006;15:1–4.
Priya S, Kaviyarasan T, Berchmans S. Naked eye detection of nitric oxide release from nitrosothiols aided by gold nanoparticles. Analyst. 2012;137:1541–3.
Vandamme K, Melkebeek V, Cox E, Deforce D, Lenoir J, Adriaens E, Vervaet C, Remon JP. Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination. Eur J Pharm Biopharm. 2010;74:202–8.
Smith DJ, Chakravarthy D, Pulfer S, Simmons ML, Hrabie JA, Citro ML, Saavedra JE, Davies KM, Hutsell TC, Mooradian DL, Hanson SR, Keefer LK. Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem. 1996;39:1148–56.
Shishido SM, Seabra AB, Loh W, de Oliveira MG. Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release. Biomaterials. 2003;24:3543–53.
Williams DLH. The chemistry of S-nitrosothiols. Acc Chem Res. 1999;32:869–76.
Wink DA, Mitchel JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med. 1998;25:434–56.
Hassett DJ, Schweizer HP, Ohman DE. Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J Bacteriol. 1995;177:6330–7.
Polack B, Dacheux D, Delic-Attree I, Toussaint B, Vignais PM. Role of manganese superoxide dismutase in a mucoid isolate of Pseudomonas aeruginosa: adaptation to oxidative stress. Infect Immun. 1996;64:2216–19.
Nunoshiba T, deRojas-Walker T, Wishnok JS, Tannenbaum SR, Demple B. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc Natl Acad Sci USA. 1993;90:9993–7.
Fukuto JM, Cho JY, Switzer CH. The chemical properties of nitric oxide and related nitrogen oxides. In: Ignarro LJ, editor. Nitric oxide: biology and pathology. San Diego: Academic Press; 2000.
Fridovich I. The biology of oxygen radicals. Science. 1978;201:875–80.
Simoes MMDSG, de Oliveira MG. Poly(vinyl alcohol) films for topical delivery of S-nitrosoglutathione: effect of freezing-thawing on the diffusion properties. J Biomed Mater Res Part B Appl Biomater. 2010;93B:416–24.
Engelsman AF, Krom BP, Busscher HJ, Van Dam GM, Ploeg RJ, Van der Mei HC. Antimicrobial effects of an NO-releasing poly(ethylene vinylacetate) coating on soft-tissue implants in vitro and in a murine model. Acta Biomater. 2009;5:1905.
Acknowledgments
The author S. Priya acknowledges CSIR, New Delhi for granting the financial support for the above work in the form of junior research fellowship. The authors also acknowledge the funding received from CSIR network project (NWP0035 and M2D) for this work to be carried out.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Priya, S., Nithya, R. & Berchmans, S. S-Nitrosothiol tethered polymer hexagons: synthesis, characterisation and antibacterial effect. J Mater Sci: Mater Med 25, 1–10 (2014). https://doi.org/10.1007/s10856-013-5032-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-013-5032-0